iBio Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)			1 Months Ended	3 Months Ended	9 Months Ended
Subsequent Events (Details) - USD ($)	Apr. 29, 2025	Apr. 21, 2025	Apr. 30, 2025	Mar. 31, 2025	Mar. 31, 2025	Jun. 30, 2024
Subsequent Event [Line Items]
Fair value of shared issued (the credit) to settle license fee payable to AstralBio					$ 750,000
Indefinite-lived intangible assets				$ 5,003,000	$ 5,003,000	$ 5,003,000
Pre-Funded Warrants
Subsequent Event [Line Items]
Proceeds from exercise of warrants		$ 80
At Market Issuance Sales Agreement \| Placement Agents \| At-The-Market Offerings \| Common Stock
Subsequent Event [Line Items]
Common stock, shares issued				32,167
Net proceeds from sale of equity				$ 102,000
Subsequent Events \| Pre-Funded Warrants
Subsequent Event [Line Items]
Warrants, shares exercised		803,508
Subsequent Events \| At Market Issuance Sales Agreement \| Placement Agents \| At-The-Market Offerings \| Common Stock
Subsequent Event [Line Items]
Common stock, shares issued			22,812
Net proceeds from sale of equity			$ 60,000
Subsequent Events \| Exclusive License Agreement (Activin-E) with AstralBio
Subsequent Event [Line Items]
Payment of upfront licensing fee		$ 750,000
Fair value of shared issued (the credit) to settle license fee payable to AstralBio		750,000
Aggregate potential milestone payments payable in licensing agreement		$ 28,000,000
Equity ownership (ceiling)		19.90%
Notice period to cancel licensing agreement		45 days
Notice period to cancel licensing agreement (material breach of contract)		90 days
Indefinite-lived intangible assets		$ 750,000
Subsequent Events \| Warrant Inducement Agreement \| Pre-Funded Warrants
Subsequent Event [Line Items]
Warrants, shares exercised	5,626,685
Warrants, exercise price	$ 0.86
Subsequent Events \| Warrant Inducement Agreement \| Inducement Warrants
Subsequent Event [Line Items]
Equity ownership (ceiling)	4.99%
Proceeds from exercise of warrants	$ 6,200,000
Warrants, shares issued	11,253,370
Proceeds per share (inducement warrants)	$ 0.125
Warrants, exercise price	$ 0.86
Warrants, exercisable term	5 years
Number of days to file a registration statement	45 days
Warrant exercise, common stock ownership limitation (at the election of the holder)	9.99%
Subsequent Events \| Warrant Inducement Agreement \| Chardan Capital Markets
Subsequent Event [Line Items]
Warrants, shares exercised	3,482,455
Warrants, exercise price	$ 0.86
Subsequent Events \| Warrant Inducement Agreement \| Chardan Capital Markets \| Inducement Warrants
Subsequent Event [Line Items]
Fees for warrant inducement agreement to sales agent	$ 217,000